Skip to main content

Ordering Mifeprex*

We are pleased that you wish to become a provider of Mifeprex.

Mifeprex is only available direct from Danco Laboratories' distributor. To establish your account:

  • Read the Prescriber's Agreement
  • Complete and sign the Account Setup Form
  • Fax the Account Setup Form to Danco Laboratories' distributor at 1-866-227-3343

Download the Prescriber's Agreement/Account Setup Form.

Your account information will be kept strictly confidential. If you oversee more than one office facility, you will need to list each facility on your order form prior to shipping the first order. If you have any questions regarding account setup or ordering Mifeprex, please call 1-877-432-7596.

The distributor will call to finalize your account setup and take your first order. This is a one-time only process; subsequent orders may be phoned in. Once your account has been established, you will usually receive your order within 24 hours. Unopened, unused product may be returned for a refund or exchange up to a year after the expiration date.

Patient information materials, including Medication Guides and chart-sized Patient Agreement Forms, will be provided together with your order of Mifeprex. If you would like additional patient information materials you may download them by clicking here. You can also order additional materials to be sent directly to your office by downloading the Reimbursement/Additional Materials Order Form and faxing it to the distributor.

Please review the requirements outlined in Providing Mifeprex prior to downloading the Prescriber's Agreement/Account Setup Form.

To view the downloaded Prescriber's Agreement/Account Setup Form, you need Adobe Acrobat Reader (a free program) installed on your computer. If you do not have this program installed on your computer, you can download it from Adobe's Web site.

IMPORTANT SAFETY INFORMATION

Serious and sometimes fatal infections and bleeding occur very rarely following spontaneous, surgical, and medical abortions, including following Mifeprex use. No causal relationship between the use of Mifeprex and misoprostol and these events has been established. A high index of suspicion is needed to rule out serious and rarely fatal infections (e.g. Clostridium sordellii) and sepsis that can present without fever, bacteremia or significant findings on a pelvic exam, with or without abdominal pain, but with leukocytosis with a marked left shift, tachycardia, hemoconcentration, and general malaise.

Cramping and bleeding are expected; bleeding may continue for 9-16 days. 5-8% of women will need a surgical procedure to end a pregnancy or stop heavy bleeding.

Patients should be counseled to seek immediate medical attention if they experience sustained fever (100.4° F or higher), severe abdominal pain, prolonged heavy vaginal bleeding, syncope or general malaise more than 24 hours after taking misoprostol.

Mifeprex should not be used in cases of confirmed or suspected ectopic pregnancy, as Mifeprex is not effective in terminating these pregnancies. Physicians may need to consider the possibility of a ruptured ectopic pregnancy, even if efforts were made to rule out an ectopic pregnancy, because an ectopic pregnancy may have been missed.

Please see full Prescribing Information for Mifeprex.

Mifeprex* is a registered trademark
of Danco Laboratories, LLC
1-877-4 Early Option
1-877-432-7596
info@earlyoptionpill.com
FDA approved since 2000.
A safe and effective non-surgical option for ending early pregnancy.